Celularity (CELUW) Cash from Financing Activities (2019 - 2025)

Celularity (CELUW) reported Cash from Financing Activities of $11.2 million for Q4 2025, up 1644.95% year-over-year from $643000.0 in Q4 2024, and up 222.6% quarter-over-quarter from $3.5 million in Q3 2025.

Celularity (CELUW) Cash from Financing Activities (2019 - 2025) Analysis & Trends

Celularity (CELUW) has 7 years of Cash from Financing Activities data on file, last reported at $11.2 million in Q4 2025.

  • Cash from Financing Activities for Q4 2025 came in at $11.2 million, up 1644.95% year-over-year; the trailing twelve-month figure through Dec 2025 was $18.6 million (up 178.3% YoY), and the FY2025 annual result was $18.6 million, up 178.3% from the prior year.
  • Cash from Financing Activities advanced to $11.2 million in Q4 2025 per CELUW's latest filing, from $3.5 million in the prior quarter.
  • Over five years, Cash from Financing Activities peaked at $100.4 million in Q3 2021 and troughed at -$4.8 million in Q1 2021.
  • A 5-year average of $13.4 million and a median of $3.7 million in 2021 frame the typical range for Cash from Financing Activities.
  • The sharpest annual moves came in 2021 and 2024: Cash from Financing Activities tumbled 219.87% in 2021, then surged 4692.86% in 2024.
  • A 5-year view of Cash from Financing Activities shows it stood at -$1.0 million in 2021, then soared by 266.17% to $1.7 million in 2022, then sank by 100.83% to -$14000.0 in 2023, then surged by 4692.86% to $643000.0 in 2024, then soared by 1644.95% to $11.2 million in 2025.
  • Business Quant data shows CELUW's Cash from Financing Activities at $11.2 million in Q4 2025, $3.5 million in Q3 2025, and $1.6 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 7.00 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -600,000.00
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 53,000.00
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -538.80 Mn
9 Abivax 91.96 Bn 91.96 Bn - 85,464.43
10 Celularity - - -3.27 Mn 11.22 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 11.22 Mn
Dec 31, 2025 11.22 Mn
Sep 30, 2025 3.48 Mn
Sep 30, 2025 3.48 Mn
Jun 30, 2025 1.63 Mn
Jun 30, 2025 1.63 Mn
Mar 31, 2025 2.32 Mn
Mar 31, 2025 2.32 Mn
Dec 31, 2024 643,000.00
Dec 31, 2024 643,000.00
Sep 30, 2024 -79,000.00
Sep 30, 2024 -79,000.00
Jun 30, 2024 -90,000.00
Jun 30, 2024 -90,000.00
Mar 31, 2024 6.23 Mn
Mar 31, 2024 6.23 Mn
Dec 31, 2023 -14,000.00
Dec 31, 2023 -14,000.00
Sep 30, 2023 5.74 Mn
Sep 30, 2023 5.74 Mn